tiprankstipranks
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
PremiumPress ReleasesBiogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
22d ago
Biogen granted marketing authorization for Qalsody by EC
PremiumThe Fly
Biogen granted marketing authorization for Qalsody by EC
22d ago
Biogen reports Leqembi approved for treatment of Alzheimer’s in South Korea
PremiumThe Fly
Biogen reports Leqembi approved for treatment of Alzheimer’s in South Korea
24d ago
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences
PremiumPress ReleasesBiogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences
1M ago
Biogen to acquire Human Immunology Biosciences for $1.15B upfront
PremiumThe Fly
Biogen to acquire Human Immunology Biosciences for $1.15B upfront
1M ago
Biogen says won’t exercise option to license and lead development of BIIB121
PremiumThe Fly
Biogen says won’t exercise option to license and lead development of BIIB121
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100